US-guided percutaneous cryoablation of prostate cancer

Radiology

Volumn 192, Issue 3, 1994, Pages 769-776

  Lee, Fred ^a   Bahn, Duke K ^a   McHugh, Timothy A ^a   Onik, Gary M ^a   Lee Jr , Fred T ^b  

^a Crittenton Hospital Medical Center   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Cryotherapy; Prostate, neoplasms; Prostate, surgery; Ultrasound (US), guidance

Indexed keywords

ANDROGEN; ANTIANDROGEN; FLUTAMIDE; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN;

ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CRYOSURGERY; HUMAN; MALE; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SURGERY; SURGICAL ANATOMY; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0027994196     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.192.3.8058945     Document Type: Article

References (30)

1. Boring CC, Squires TS, Tong T. Cancer statistics 1993. CA 1993; 43:7-26.
2. Scardino PT. Early detection of prostate cancer. Urol Clin North Am 1989; 16:625-655.
3. Chiarodo A. National Cancer Institute roundtable on prostate cancer: future research directions. Cancer Res 1991; 51: 2498-2505.
4. Jewett HJ. Radical perineal prostatectomy for palpable clinically localized nonobstructive cancer: experience at The Johns Hopkins Hospital 1909-1963. J Urol 1980; 124:492-494.
5. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy: time trends, geographic variation, and outcomes. JAMA 1993; 269:2633-2636.
6. Whitmore WF. Natural history of low-stage prostatic cancer and the impact of early detection. Urol Clin North Am 1990; 17:689-697.
7. Herr HW. The patient, disease status, and treatment options for prostate cancer: stages B1 and B2. Prostate 1983; 4:447-459.
8. Fowler FJ Jr, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy: the national Medicare experience: 1988-1990 (updated June, 1993). Urology 1993; 42:622-629.
9. Hautmann RE, Sauter TW, Wenderoth UK. Radical retroprobe prostatectomy: morbidity and urinary continence in 418 consecutive cases. Urology 1994; 43(suppl):46-51.
10. Adolfsson J. Deferred treatment of low grade stage T3 prostate cancer without distant metastases. J Urol 1993; 149:326-329.
11. Gonder M, Soanes W, Shulman S. Cryosurgical treatment of the prostate. Invest Urol 1966; 3:372-378.
12. Addonizio JC. Another look at cryoprostatectomy. Cryobiology 1982; 19:223-227.
13. Loening SA, Bonney WW, Fallon B, et al. Cryotherapy. Prostate 1984; 5:199-204.
14. Walsh PC, Epstein JI, Lowe FC. Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol 1987; 138:823-827.
15. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993; 72:1291-1298.
16. Monfette G, Dupont A, Labrie F. Temporary combination therapy with flutamide and tryptex as adjuvant to radical prostatectomy for the treatment of early stage prostate cancer. In: Labrie F, Lee F, Dupont A, eds. Early stage prostate cancer: diagnosis and choice of therapy. New York, NY: Elsevier Science, 1989; 41-51.
17. Shearer RJ, Davies JH, Gelister JSK, Dearnaley DP. Hormonal cytoreduction and radiotherapy for carcinoma of the prostate. Br J Urol 1992; 69:521-524.
18. Tetu B, Labrie F, Dupont A, Monfette G. Histopathologic effect of combination therapy on normal prostate and prostatic adenocarcinoma. In: Labrie F, Lee F, Dupont A, eds. Early stage prostate cancer: diagnosis and choice of therapy. New York, NY: Elsevier Science, 1989; 63-75.
19. Fair WF, Aprikian A, Reuter V. Neoadjuvant hormonal manipulation: a strategy for chemoprevention trials. J Cell Biochem 1992; 16H(suppl):118-121.
20. Lee F, Siders DB, Newby JE, McHugh TA, Solomon MH. The role of transrectal ultrasound-guided staging biopsy and androgen ablation therapy prior to radical prostatectomy. Clin Invest Med 1993; 16: 463-483.
21. Myers RP, Larson-Keller JJ, Bergstralh EJ, Zincke H, Oesterling J, Lieber MM. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term follow-up. J Urol 1992; 147:910-915.
22. Lee F, Torp-Pedersen ST, Siders DB, Littrup PJ, McLeary RD. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 1989; 170:609-615.
23. Lee F, Littrup PJ, McLeary RD, et al. Needle aspiration and core biopsy of prostate cancer: comparative evaluation with biplanar transrectal US guidance. Radiology 1987; 163:515-520.
24. Lee F, Siders DB, Torp-Pedersen ST, Kirscht JL, McHugh TA, Mitchell AE. Prostate cancer: transrectal ultrasound and pathology comparison - a preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer. Cancer 1991; 67(suppl):1132-1142.
25. Terris MK, McNeal JE, Freiha FS, Stamey TA. Efficacy of transrectal ultrasoundguided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer. J Urol 1993; 149:1035-1039.
26. Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989; 142:763-768.
27. Littrup PJ, Kane RA, Williams CR, et al. Determination of prostate volume with transrectal US for cancer screening. Radiology 1991; 178:537-542.
28. Pinault S, Tetu B, Gagnon J, Monfette G, Dupont A, Labrie F. Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide. Urology 1992; 39:254-261.
29. Gage A. Cryosurgery in the treatment of cancer. Surg Gynecol Obstet 1992; 174:73-92.
30. Villers A, McNeal JE, Freiha FS, BocconGibod L, Stamey TA. Invasion of Denonvilliers' fascia in radical prostatectomy specimens. J Urol 1993; 149:793-798.